Table 3 CMR Characteristics: Healthy Controls and Patients with chronic heart failure.
From: Epicardial adipose tissue in patients with heart failure
Controls n = 32 | Patients with CHF n = 66 | p-value | |
|---|---|---|---|
LV-EF (%) | 58 ± 5 | 27 ± 9 | < 0.0001 |
LV-EDM (g) | 125 ± 35 | 207 ± 56 | < 0.0001 |
Indexed LV-EDM (g/m2) | 64 ± 15 | 109 ± 28 | < 0.0001 |
LV-ESV (ml) | 75 ± 85 | 211 ± 76 | < 0.0001 |
LV-EDV (ml) | 141 ± 36 | 294 ± 86 | < 0.0001 |
LV-EDD (mm) | 50 ± 5 | 69 ± 8 | < 0.0001 |
LVRI g/ml | 0.9 ± 0.2 | 0.7 ± 0.2 | 0.001 |
RV-EF (%) | 58 ± 6 | 42 ± 14 | < 0.0001 |
RV-ESV (ml) | 55 ± 16 | 103 ± 64 | 0.0001 |
RV-EDV (ml) | 137 ± 32 | 168 ± 68 | 0.02 |
EAT volume (ml) | 71 ± 13 | 46 ± 11 | < 0.0001 |
Indexed EAT volume (ml/m2) | 36 ± 5 | 24 ± 5 | < 0.0001 |
EAT mass (g) | 67 ± 13 | 43 ± 11 | < 0.0001 |
Indexed EAT mass (g/m2) | 34 ± 4 | 22 ± 5 | < 0.0001 |
EAT mass/LV-EDM ratio | 0.54 ± 0.1 | 0.21 ± 0.1 | < 0.0001 |